Kota Yano

Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

Kota Yano, Kanji Yamaguchi, Yuya Seko et al. · Laboratory Investigation · 2021 · 49 citations

Inflammation, Metabolic Syndrome, Obesity +15

Effect of pemafibrate on fatty acid levels and liver enzymes in non‐alcoholic fatty liver disease patients with dyslipidemia: A single‐arm, pilot study

Yuya Seko, Kanji Yamaguchi, Atsushi Umemura et al. · Hepatology Research · 2020 · 35 citations

Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non‐alcoholic fatty liver disease

Yuya Seko, Kanji Yamaguchi, Nozomi Tochiki et al. · Liver International · 2020 · 32 citations

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat

Shinya Okishio, Kanji Yamaguchi, Hiroshi Ishiba et al. · Scientific Reports · 2020 · 16 citations · Full text

Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells

Aya Takahashi, Atsushi Umemura, Kota Yano et al. · Frontiers in Oncology · 2021 · 15 citations · Full text

Immunology, Immune Regulation, Hepatocellular Carcinoma Cells +25